Ambac (AMBC)
(Delayed Data from NYSE)
$12.51 USD
0.00 (0.00%)
Updated Jul 2, 2024 04:00 PM ET
After-Market: $12.50 -0.01 (-0.08%) 7:58 PM ET
1-Strong Buy of 5 1
B Value F Growth A Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$12.51 USD
0.00 (0.00%)
Updated Jul 2, 2024 04:00 PM ET
After-Market: $12.50 -0.01 (-0.08%) 7:58 PM ET
1-Strong Buy of 5 1
B Value F Growth A Momentum C VGM
Zacks News
Aegon (AEG) Wraps Up EUR 1.535B Planned Share Repurchase
by Zacks Equity Research
Aegon (AEG) has a new repurchase program of EUR 200 million, which was expected to start from this month and complete by 2024-end.
Here's Why You Should Hold RenaissanceRe (RNR) Stock for Now
by Zacks Equity Research
RenaissanceRe (RNR) is expected to benefit from rising premiums, net investment income, and underwriting capabilities.
MetLife (MET), Micruity Unite to Enhance Retirement Solutions
by Zacks Equity Research
MetLife (MET) expands collaboration with Micruity in a bid to develop MetLife's Universal Digital Platform and enhance access to retirement solutions.
Here's Why You Should Hold Marsh & McLennan (MMC) Stock Now
by Zacks Equity Research
Marsh & McLennan (MMC) is well-poised for growth on the back of rising demand for services, revenue growth and margin expansion outlook.
Here's Why Investors Should Retain AON Stock in Their Portfolio
by Zacks Equity Research
AON's Health Solutions segment is expected to witness 5.7% organic revenue growth in 2024, exceeding $2.8 billion in total.
Marsh & McLennan (MMC) to Enhance Wealth Unit With Acquisition
by Zacks Equity Research
Marsh & McLennan (MMC) agrees to acquire Cardano in a bid to expand its offerings in the UK and the Netherlands.
AON Leads $350M Insurance Initiative for Ukraine Recovery
by Zacks Equity Research
The move from AON and its partners is expected to provide protection for capital, which is likely to aid investments in the country.
MetLife (MET) Explores Acquisition of Hayfin Capital Management (revised)
by Zacks Equity Research
MetLife (MET) is in talks to consider the Hayfin Capital Management acquisition, expanding its presence in the private capital market.
ProAssurance (PRA) Rises 8.5% in 3 Months: More Growth Ahead?
by Zacks Equity Research
Thanks to its cost-controlling efforts, ProAssurance's (PRA) expenses are expected to decline in the coming quarters.
MetLife (MET) Explores Acquisition of Hayfin Capital Management
by Zacks Equity Research
MetLife (MET) is in talks to consider the Hayfin Capital Management acquisition, expanding its presence in the private capital market.
Marsh & McLennan (MMC) Arm Buys Perkins Insurance in West Texas
by Zacks Equity Research
The acquisition is expected to boost Marsh & McLennan's (MMC) footprint in the West Texas market and enhance its service offerings.
MetLife's (MET) My Leave Navigator to Boost Leave Experience
by Zacks Equity Research
MetLife (MET) is introducing tailored products according to the market demand, enabling better market penetration and generating steady premiums.
Why You Should Retain Marsh & McLennan (MMC) Stock for Now
by Zacks Equity Research
Marsh & McLennan's (MMC) is well-poised for growth on the back of increasing demand for services, revenue growth and margin expansion outlook.
Aflac (AFL) to Acquire 40% Stake in Tree Line Capital for $100M
by Zacks Equity Research
Aflac (AFL) is now poised to reap the rewards of high returns from private credits.
Why Investors Are Buying RenaissanceRe (RNR) Shares Now
by Zacks Equity Research
RenaissanceRe's (RNR) improving yields from its fixed maturity and short-term portfolios amid a high interest rate environment are expected to enhance its net investment income.
Is Ambac (AMBC) Stock a Solid Choice Right Now?
by Zacks Equity Research
Ambac (AMBC) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
Ambac Financial Group, Inc. (AMBC) Hits Fresh High: Is There Still Room to Run?
by Zacks Equity Research
Ambac (AMBC) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Should Value Investors Buy Ambac (AMBC) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Are Investors Undervaluing Ambac (AMBC) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
The Zacks Analyst Blog Highlights Ambac, Pangaea Logistics Solutions, MoneyLion, OppFi and Carrols Restaurant Group
by Zacks Equity Research
Ambac, Pangaea Logistics Solutions, MoneyLion, OppFi and Carrols Restaurant Group are part of the Zacks top Analyst Blog
Buy These 5 Small-Cap Stocks to Tap Year-End Rally
by Sanghamitra Saha
A less-hawkish Fed, the upcoming holiday season and decent U.S. economic growth may lead to small-cap investing. Investors can buy the likes of Ambac (AMBC), Pangaea Logistics Solutions (PANL), MoneyLion (ML), OppFi (OPFI) and Carrols Restaurant Group (TAST).
Ambac Financial Group (AMBC) Q2 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Ambac (AMBC) delivered earnings and revenue surprises of 216.67% and 27.05%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Outfront Media (OUT) Lags Q2 FFO and Revenue Estimates
by Zacks Equity Research
Outfront Media (OUT) delivered FFO and revenue surprises of -7.45% and 0.85%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Allstate (ALL) Reports Q2 Loss, Lags Revenue Estimates
by Zacks Equity Research
Allstate (ALL) delivered earnings and revenue surprises of -15.40% and 0.59%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
3 Stocks to Buy on New Analyst Coverage
by Shrabana Mukherjee
The recent surge in analyst coverage for stocks such as Ligand (LGND), Ambac (AMBC) and Exponent (EXPO) indicates the potential for significant price appreciation in the near term.